Table 3.

Association of CaSR Expression With Lethal Prostate Cancer Among Men Diagnosed With Prostate Cancer Between 1983 and 2009 in the HPFS and the PHS

	CaSR 0 to <2	CaSR ≥2
Lethal events, n	63	20
Total, n	1092	149
Person-time, y	14 729	2157
Model 1, HR (95% CI)a	1.0 (reference)	2.2 (1.3–3.6)
Model 2, HR (95% CI)b	1.0 (reference)	2.2 (1.4–3.7)
Model 3, HR (95% CI)c	1.0 (reference)	2.0 (1.2–3.3)
Model 4, HR (95% CI)d	1.0 (reference)	2.1 (1.2–3.5)

^aTime to event analysis using Cox proportional hazards model adjusted for age at diagnosis.

^bModel 1 + BMI at diagnosis and Gleason grade.

^cModel 2 + pathological TNM.

^dModel 3 + cohort.